1
|
Cui Y, Liu Y, Pan X, Bao Y, Shi W, Cao L. Dilong (Earthworm) alleviates cyclophosphamide-induced brain injury by reducing mitochondrial damage in neuronal cells. Neuroscience 2024:S0306-4522(24)00761-9. [PMID: 39742944 DOI: 10.1016/j.neuroscience.2024.12.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2024] [Revised: 12/21/2024] [Accepted: 12/27/2024] [Indexed: 01/04/2025]
Abstract
The experiment was designed to explore the effects and mechanism of Dilong on alleviating cyclophosphamide (CTX)-induced brain injury in mice. Fifty male SPF Kunming mice aged 6-8 weeks were randomly divided into five groups: Group A served as the control group; Group B received intraperitoneal injection of CTX; Groups C, D, and E were administered Dilong at doses of 100, 200, and 400 mg/kg respectively for 14 days after intraperitoneal injection of CTX. Results showed that after modeling, the movement speed of mice significantly decreased (P < 0.05), and the number of neurons in the hippocampus and cortex decreased. Dilong can mitigate the behavioral abnormalities and reduction of brain neuronal cells caused by CTX. CTX had no significant effect on the number of astrocytes, microglia, and microglia M1 and M2 polarization, but it had a significant damaging effect on neuronal cells (P < 0.05). The mechanism of action is that CTX causes a decrease in cellular mitochondrial respiratory enzyme activity (P < 0.05) and abnormal mitochondrial structure, which leads to the activation of the cellular scorching pathway. Dilong significantly increased mitochondrial respiratory enzyme activity (P < 0.05), and the mitochondrial structure was restored to some extent. By significantly reducing NLRP3/TLR4/caspase1/pro caspase1/GSDMD (P < 0.05), it increased neuronal cell survival. This resulted in an increase in neuronal cell survival, thus exerting a protective effect on the brain.
Collapse
Affiliation(s)
- Yuqing Cui
- College of Veterinary Medicine, Southwest University, Rongchang, Chongqing 402460, China; Traditional Chinese Veterinary Research Institute, Southwest University, Rongchang, Chongqing 402460, China
| | - Yishan Liu
- Institute of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China; (r)Beijing Municipal Bureau of Agriculture and Rural Affairs, Beijing 10000, China
| | - Xingliang Pan
- (r)Beijing Municipal Bureau of Agriculture and Rural Affairs, Beijing 10000, China
| | - Yongzhan Bao
- Institute of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China; Hebei Provincial Engineering Center for Chinese Veterinary Herbal Medicine, Baoding 071000, China
| | - Wanyu Shi
- Institute of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China; Hebei Provincial Engineering Center for Chinese Veterinary Herbal Medicine, Baoding 071000, China
| | - Liting Cao
- College of Veterinary Medicine, Southwest University, Rongchang, Chongqing 402460, China; Traditional Chinese Veterinary Research Institute, Southwest University, Rongchang, Chongqing 402460, China.
| |
Collapse
|
2
|
Tang S, Wang M, Peng Y, Liang Y, Lei J, Tao Q, Ming T, Shen Y, Zhang C, Guo J, Xu H. Armeniacae semen amarum: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics. Front Pharmacol 2024; 15:1290888. [PMID: 38323080 PMCID: PMC10844384 DOI: 10.3389/fphar.2024.1290888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Accepted: 01/10/2024] [Indexed: 02/08/2024] Open
Abstract
Armeniacae semen amarum-seeds of Prunus armeniaca L. (Rosaceae) (ASA), also known as Kuxingren in Chinese, is a traditional Chinese herbal drug commonly used for lung disease and intestinal disorders. It has long been used to treat coughs and asthma, as well as to lubricate the colon and reduce constipation. ASA refers to the dried ripe seed of diverse species of Rosaceae and contains a variety of phytochemical components, including glycosides, organic acids, amino acids, flavonoids, terpenes, phytosterols, phenylpropanoids, and other components. Extensive data shows that ASA exhibits various pharmacological activities, such as anticancer activity, anti-oxidation, antimicrobial activity, anti-inflammation, protection of cardiovascular, neural, respiratory and digestive systems, antidiabetic effects, and protection of the liver and kidney, and other activities. In clinical practice, ASA can be used as a single drug or in combination with other traditional Chinese medicines, forming ASA-containing formulas, to treat various afflictions. However, it is important to consider the potential adverse reactions and pharmacokinetic properties of ASA during its clinical use. Overall, with various bioactive components, diversified pharmacological actions and potent efficacies, ASA is a promising drug that merits in-depth study on its functional mechanisms to facilitate its clinical application.
Collapse
Affiliation(s)
- Shun Tang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Minmin Wang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yuhui Peng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yuanjing Liang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jiarong Lei
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Qiu Tao
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Tianqi Ming
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yanqiao Shen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Chuantao Zhang
- Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jinlin Guo
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Haibo Xu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmacology, School of Pharmaceutical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|